Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akebia Therapeutics, Inc. (AKBA) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Akebia Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1517022.
Total stock buying since 2015: $18,976,843.
Total stock sales since 2015: $3,528,235.
Total stock option exercises since 2015: $307,785.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 259,530 | $643,132 | 35,100 | $34,245 |
| 2024 | 0 | $0 | 250,285 | $383,675 | 0 | $0 |
| 2023 | 0 | $0 | 529,922 | $546,921 | 0 | $0 |
| 2022 | 0 | $0 | 172,410 | $365,691 | 0 | $0 |
| 2021 | 0 | $0 | 107,941 | $365,661 | 0 | $0 |
| 2020 | 0 | $0 | 44,579 | $452,604 | 0 | $0 |
| 2019 | 147,800 | $511,854 | 0 | $0 | 287,000 | $134,890 |
| 2018 | 0 | $0 | 1,000 | $14,620 | 100,000 | $47,000 |
| 2017 | 1,034,482 | $14,999,989 | 33,699 | $526,021 | 20,000 | $9,400 |
| 2016 | 0 | $0 | 14,645 | $131,198 | 25,000 | $11,750 |
| 2015 | 420,000 | $3,465,000 | 10,149 | $98,712 | 150,000 | $70,500 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 69,648 | $258,841 | 15,000 | $25,200 |
| 2025-03 | 0 | $0 | 53,553 | $98,001 | 0 | $0 |
| 2025-02 | 0 | $0 | 136,329 | $286,290 | 0 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 20,100 | $9,045 |
| 2024-05 | 0 | $0 | 46,856 | $59,038 | 0 | $0 |
| 2024-02 | 0 | $0 | 203,429 | $324,637 | 0 | $0 |
| 2023-08 | 0 | $0 | 27,000 | $31,049 | 0 | $0 |
| 2023-05 | 0 | $0 | 285,798 | $329,823 | 0 | $0 |
| 2023-03 | 0 | $0 | 146,647 | $128,753 | 0 | $0 |
| 2023-02 | 0 | $0 | 70,477 | $57,296 | 0 | $0 |
| 2022-06 | 0 | $0 | 4,567 | $1,653 | 0 | $0 |
| 2022-03 | 0 | $0 | 98,622 | $214,106 | 0 | $0 |
| 2022-02 | 0 | $0 | 63,388 | $136,598 | 0 | $0 |
| 2022-01 | 0 | $0 | 5,833 | $13,334 | 0 | $0 |
| 2021-08 | 0 | $0 | 1,042 | $2,948 | 0 | $0 |
| 2021-06 | 0 | $0 | 4,567 | $15,162 | 0 | $0 |
| 2021-04 | 0 | $0 | 9,203 | $31,288 | 0 | $0 |
| 2021-03 | 0 | $0 | 93,129 | $316,263 | 0 | $0 |
| 2020-06 | 0 | $0 | 20,127 | $239,874 | 0 | $0 |
| 2020-02 | 0 | $0 | 24,452 | $212,730 | 0 | $0 |
| 2019-11 | 147,800 | $511,854 | 0 | $0 | 0 | $0 |
| 2019-06 | 0 | $0 | 0 | $0 | 287,000 | $134,890 |
| 2018-07 | 0 | $0 | 0 | $0 | 100,000 | $47,000 |
| 2018-02 | 0 | $0 | 1,000 | $14,620 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | Ostrowski Erik (SVP, CFO, CBO & Treasurer) | Sale | 41,314 | 3.67 | 151,622 |
| 2025-06-09 | Malabre Richard C (SVP, Chief Accounting Officer) | Sale | 15,000 | 4.01 | 60,150 |
| 2025-06-09 | Malabre Richard C (SVP, Chief Accounting Officer) | Option Ex | 15,000 | 1.68 | 25,200 |
| 2025-06-04 | Malabre Richard C (SVP, Chief Accounting Officer) | Sale | 13,334 | 3.53 | 47,069 |
| 2025-03-03 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,144 | 1.83 | 13,073 |
| 2025-03-03 | Butler John P. (CEO and President) | Sale | 46,409 | 1.83 | 84,928 |
| 2025-02-03 | Malabre Richard C (SVP, Chief Accounting Officer) | Sale | 30,202 | 2.10 | 63,424 |
| 2025-02-03 | Grund Nicholas (Chief Commercial Officer) | Sale | 55,621 | 2.10 | 116,804 |
| 2025-02-03 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 50,506 | 2.10 | 106,062 |
| 2025-01-17 | Frieson Ron | Option Ex | 20,100 | .45 | 9,045 |
| 2024-05-13 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 34,840 | 1.26 | 43,898 |
| 2024-05-13 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 12,016 | 1.26 | 15,140 |
| 2024-02-29 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 8,661 | 1.58 | 13,684 |
| 2024-02-29 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,169 | 1.58 | 11,327 |
| 2024-02-29 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 5,974 | 1.58 | 9,438 |
| 2024-02-29 | Butler John P. (CEO and President) | Sale | 46,570 | 1.58 | 73,580 |
| 2024-02-27 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 10,744 | 1.52 | 16,330 |
| 2024-02-27 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 8,367 | 1.52 | 12,717 |
| 2024-02-27 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 7,411 | 1.52 | 11,264 |
| 2024-02-27 | Butler John P. (CEO and President) | Sale | 37,733 | 1.52 | 57,354 |
| 2024-02-01 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 24,311 | 1.68 | 40,842 |
| 2024-02-01 | Butler John P. (CEO and President) | Sale | 46,489 | 1.68 | 78,101 |
| 2023-08-25 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 27,000 | 1.15 | 31,049 |
| 2023-05-25 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 95,478 | 1.22 | 116,769 |
| 2023-05-25 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 63,186 | 1.22 | 77,276 |
| 2023-05-16 | Spellman David A (SVP, CFO and Treasurer) | Sale | 63,567 | 1.07 | 67,889 |
| 2023-05-16 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 63,567 | 1.07 | 67,889 |
| 2023-03-01 | Spellman David A (SVP, CFO and Treasurer) | Sale | 7,210 | .88 | 6,330 |
| 2023-03-01 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 20,412 | .88 | 17,921 |
| 2023-03-01 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 14,123 | .88 | 12,399 |
| 2023-03-01 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 13,034 | .88 | 11,443 |
| 2023-03-01 | Butler John P. (CEO and President) | Sale | 91,868 | .88 | 80,660 |
| 2023-02-27 | Spellman David A (SVP, CFO and Treasurer) | Sale | 7,539 | .81 | 6,129 |
| 2023-02-27 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 10,090 | .81 | 8,203 |
| 2023-02-27 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,539 | .81 | 6,129 |
| 2023-02-27 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 6,677 | .81 | 5,428 |
| 2023-02-27 | Butler John P. (CEO and President) | Sale | 38,632 | .81 | 31,407 |
| 2022-06-03 | Gilman Steven C | Sale | 4,567 | .36 | 1,653 |
| 2022-03-01 | Faulkingham Dell (SVP, CCO) | Sale | 6,705 | 2.17 | 14,556 |
| 2022-03-01 | Spellman David A (SVP, CFO and Treasurer) | Sale | 803 | 2.17 | 1,743 |
| 2022-03-01 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 14,978 | 2.17 | 32,517 |
| 2022-03-01 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,656 | 2.17 | 16,621 |
| 2022-03-01 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 14,507 | 2.17 | 31,494 |
| 2022-03-01 | Butler John P. (CEO and President) | Sale | 53,973 | 2.17 | 117,175 |
| 2022-02-28 | Cotreau Violetta (SVP, Chief Accounting Officer) | Sale | 3,946 | 2.15 | 8,503 |
| 2022-02-28 | Faulkingham Dell (SVP, CCO) | Sale | 6,479 | 2.15 | 13,962 |
| 2022-02-28 | Spellman David A (SVP, CFO and Treasurer) | Sale | 7,400 | 2.15 | 15,946 |
| 2022-02-28 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 6,555 | 2.15 | 14,126 |
| 2022-02-28 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,400 | 2.15 | 15,946 |
| 2022-02-28 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 6,555 | 2.15 | 14,126 |
| 2022-02-28 | Butler John P. (CEO and President) | Sale | 25,053 | 2.15 | 53,989 |
| 2022-01-03 | Cotreau Violetta (SVP, Chief Accounting Officer) | Sale | 5,833 | 2.29 | 13,334 |
| 2021-08-31 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 1,042 | 2.83 | 2,948 |
| 2021-06-07 | Gilman Steven C | Sale | 4,567 | 3.32 | 15,162 |
| 2021-04-01 | Faulkingham Dell (SVP, CCO) | Sale | 952 | 3.40 | 3,236 |
| 2021-04-01 | Spellman David A (SVP, CFO and Treasurer) | Sale | 790 | 3.40 | 2,686 |
| 2021-04-01 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 1,211 | 3.40 | 4,117 |
| 2021-04-01 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 1,081 | 3.40 | 3,675 |
| 2021-04-01 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 1,060 | 3.40 | 3,604 |
| 2021-04-01 | Butler John P. (CEO and President) | Sale | 4,109 | 3.40 | 13,970 |
| 2021-03-01 | Faulkingham Dell (CCO) | Sale | 6,749 | 3.40 | 22,919 |
| 2021-03-01 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 14,547 | 3.40 | 49,401 |
| 2021-03-01 | Burke Steven Keith (SVP, Chief Medical Officer) | Sale | 7,558 | 3.40 | 25,666 |
| 2021-03-01 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 14,285 | 3.40 | 48,511 |
| 2021-03-01 | Butler John P. (CEO and President) | Sale | 49,990 | 3.40 | 169,766 |
| 2020-06-08 | Smith Cynthia | Sale | 4,567 | 12.10 | 55,260 |
| 2020-06-08 | Gilman Steven C | Sale | 4,567 | 12.08 | 55,169 |
| 2020-06-08 | Gowen Maxine | Sale | 4,567 | 12.05 | 55,032 |
| 2020-06-01 | Faulkingham Dell (CCO) | Sale | 6,426 | 11.58 | 74,413 |
| 2020-02-28 | Dahan Michel (SVP, Chief Operating Officer) | Sale | 6,972 | 8.70 | 60,656 |
| 2020-02-28 | Hadas Nicole R. (SVP, Chief Legal Officer) | Sale | 7,050 | 8.70 | 61,334 |
| 2020-02-28 | Tubridy Karen L (SVP, Chief Development Officer) | Sale | 3,454 | 8.70 | 30,049 |
| 2020-02-28 | Amello Jason (SVP, CFO & Treasurer) | Sale | 6,976 | 8.70 | 60,691 |
| 2019-11-20 | Burke Steven Keith (SVP, Chief Medical Officer) | Buy | 27,000 | 3.58 | 96,660 |
| 2019-11-20 | Smith Cynthia | Buy | 15,000 | 3.52 | 52,800 |
| 2019-11-20 | Butler John P. (CEO and President) | Buy | 50,000 | 3.44 | 172,000 |
| 2019-11-20 | Gilman Steven C | Buy | 5,800 | 3.43 | 19,894 |
| 2019-11-20 | Adams Adrian | Buy | 50,000 | 3.41 | 170,500 |
| 2019-06-03 | Butler John P. (CEO and President) | Option Ex | 287,000 | .47 | 134,890 |
| 2018-07-11 | Butler John P. (CEO and President) | Option Ex | 100,000 | .47 | 47,000 |
| 2018-02-15 | Nash Duane | Sale | 1,000 | 14.62 | 14,620 |
| 2017-10-02 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,398 | 19.64 | 27,456 |
| 2017-10-02 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 7,803 | 19.80 | 154,460 |
| 2017-10-02 | Nash Duane | Sale | 1,188 | 19.64 | 23,332 |
| 2017-09-28 | Dahan Michel (SVP, Chief Business Officer) | Sale | 5,000 | 19.30 | 96,500 |
| 2017-08-15 | Dahan Michel (SVP, Chief Business Officer) | Sale | 5,000 | 15.00 | 75,000 |
| 2017-07-05 | Satter Muneer A (Director) | Buy | 1,034,482 | 14.50 | 14,999,989 |
| 2017-07-03 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,399 | 14.26 | 19,946 |
| 2017-07-03 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,554 | 14.26 | 22,156 |
| 2017-07-03 | Nash Duane | Sale | 990 | 14.27 | 14,127 |
| 2017-04-03 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,401 | 9.18 | 12,858 |
| 2017-04-03 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,556 | 9.18 | 14,280 |
| 2017-04-03 | Nash Duane | Sale | 991 | 9.20 | 9,119 |
| 2017-01-19 | Butler John P. (CEO and President) | Option Ex | 20,000 | .47 | 9,400 |
| 2017-01-03 | Nash Duane | Sale | 1,980 | 10.46 | 20,710 |
| 2017-01-01 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,629 | 10.49 | 17,089 |
| 2017-01-01 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,810 | 10.49 | 18,988 |
| 2016-10-03 | Nash Duane | Sale | 1,981 | 8.96 | 17,745 |
| 2016-10-01 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,401 | 8.96 | 12,545 |
| 2016-10-01 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,556 | 8.96 | 13,933 |
| 2016-07-06 | Nash Duane | Sale | 1,980 | 7.48 | 14,818 |
| 2016-07-05 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,402 | 7.47 | 10,468 |
| 2016-07-05 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,557 | 7.47 | 11,626 |
| 2016-04-04 | Dahan Michel (SVP, Chief Business Officer) | Sale | 1,401 | 9.41 | 13,183 |
| 2016-04-04 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,556 | 9.41 | 14,641 |
| 2016-01-15 | Butler John P. (CEO and President) | Option Ex | 25,000 | .47 | 11,750 |
| 2016-01-04 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,811 | 12.28 | 22,239 |
| 2015-10-02 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,484 | 8.67 | 12,860 |
| 2015-10-02 | Nash Duane (Director) | Sale | 996 | 8.65 | 8,617 |
| 2015-07-02 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,484 | 9.54 | 14,160 |
| 2015-07-02 | Nash Duane (Director) | Sale | 996 | 9.53 | 9,489 |
| 2015-05-26 | Butler John P. (CEO and President) | Option Ex | 50,000 | .47 | 23,500 |
| 2015-04-22 | Satter Muneer A (Director) | Buy | 420,000 | 8.25 | 3,465,000 |
| 2015-04-02 | Hadas Nicole R. (SVP, General Counsel, Sec.) | Sale | 1,483 | 9.09 | 13,477 |
| 2015-04-02 | Nash Duane (Director) | Sale | 996 | 9.09 | 9,051 |
| 2015-03-09 | Butler John P. (CEO and President) | Option Ex | 100,000 | .47 | 47,000 |
| 2015-01-02 | Hadas Nicole R. (VP General Counsel & Secretary) | Sale | 1,715 | 11.46 | 19,655 |
| 2015-01-02 | Nash Duane (Director) | Sale | 995 | 11.46 | 11,403 |
Insider trading activities including stock purchases, stock sales, and option exercises of AKBA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Akebia Therapeutics, Inc. (symbol AKBA, CIK number 1517022) see the Securities and Exchange Commission (SEC) website.